Case Points to Link Between Crohn's Treatment, Cancer (HealthDay)

HealthDay - WEDNESDAY, July 16 (HealthDay News) -- An unusual case involving a sudden remission of lung cancer highlights the carcinogenic potential of certain drugs used to treat Crohn's disease, experts say.

Cancer Survival Depends on Where You Live (HealthDay)

HealthDay - WEDNESDAY, July 16 (HealthDay News) -- Your odds of surviving cancer depend on which country you live in. And, in the United States, it also depends on whether you're black or white, a new study finds.

Case Points to Link Between Crohn's Treatment, Cancer (HealthDay)

HealthDay - WEDNESDAY, July 16 (HealthDay News) -- An unusual case involving a sudden remission of lung cancer highlights the carcinogenic potential of certain drugs used to treat Crohn's disease, experts say.

Hormone Therapy Not Shown to Benefit Older Patients with Early Prostate Cancer (American Cancer Society)

American Cancer Society - A study of nearly 20,000 men aged 66 and older with early-stage prostate cancer found that those who were prescribed androgen deprivation hormone therapy instead of other treatments were no better off than their counterparts who adopted a "wait and see" approach. However, younger men who aren't good candidates for surgery or radiation should still consider the therapy, which reduces androgen levels and often makes prostate cancers shrink or grow more slowly.

Cancer Survival Depends on Where You Live (HealthDay)

HealthDay - WEDNESDAY, July 16 (HealthDay News) -- Your odds of surviving cancer depend on which country you live in. And, in the United States, it also depends on whether you're black or white, a new study finds.

Gene Profiles Might Help Guide Lung Cancer Care (HealthDay)

HealthDay - SUNDAY, July 20 (HealthDay News) -- A sweeping genetic analysis suggests that the activity of certain genes might someday allow doctors to predict which lung cancer patients need more aggressive therapies and which do not.